Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Valbenazine (Ingrezza): The First FDA-Approved Treatment for Tardive Dyskinesia.

Stepan Uhlyar,Jose A Rey

P & T : a peer-reviewed journal for formulary management（2018）

Cited 28|Views1
No score
Abstract
Valbenazine (Ingrezza): the first FDA-approved treatment for tardive dyskinesia.
More
Translated text
Key words
tardive dyskinesia,ingrezza,treatment,fda-approved
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined